Introductory Video
Featured Staff Profile
Healing MS Newsletter
IMSMP is excited to launch this first issue of our new newsletter: HEALING MS.
IMSMP Up to the MinuteView More
The U.S. Food and Drug Administration (FDA) has released a statement regarding Chronic Cerebrospinal Venous Insufficiency (CCSVI) Treatment for Multiple Sclerosis also known as the "Liberation Procedure." For patients who have expressed interest in CCSVI, please read their statement in the link below. Your physicians at the IMSMP support the recommendations stated by the FDA.
On Wednesday, May 9, 2012, Dr. Timothy Vollmer, from the Rocky Mountain MS Center, spoke at Grand Rounds on Novel Immune Targets in MS and Treatment Implications. All the researchers from MSRCNY were in attendance as well as the clinical staff from the IMSMP.
THANK YOU to all who attended the 2012 Cocktails for a Cure. This year's event was our most successful yet with over 500 tickets sold and more than $25,000.00 raised for research at the Multiple Sclerosis Research Center of New York! Our deepest gratitude to Dana Schwartz and Ryan Cohen (pictured below). This dynamic duo donates their time and collaborates on this event year after year!
Since the November 2011 announcement, there has been tremendous interest in the IRB approved stem cell trial for multiple sclerosis. Due to the overwhelming response, the IMSMP and MSRCNY hope to expand the study to include 40 participants instead of the initially approved 20. The first six participants have already been selected, but therapy will not be initiated until funding through grants and private donors has been obtained. There are certain inclusion and exclusion criteria that must...
Dr. Sylvie Destian spoke at this morning's Grand Rounds on the topic of 'Imaging of Multiple Sclerosis'. She is a neuroradiologist at SUNY Syracuse and will be associated with the new MRI facility on the 3rd floor. This talk focused primarily on specialized imaging techniques for the clinical evaluation of Multiple Sclerosis as well as techniques for MS research. She also discussed the various disorders which can appear similar to MS on MRI.
Please check out the center’s new Facebook page! Click “LIKE” on the IMSMP’s site page www.facebook.com/IMSMP and help support the battle against Multiple Sclerosis. You can also help spread the news of our page to friends and family by updating your status with a direct link to the page for others to see.
Here are some answers to common questions regarding our new stem cell trial. Our websites will have more information shortly on pages devoted to our stem cell work.
How did the trial get approved?
Dr. Ralph Benedict, Professor of Neurology, Psychiatry and Psychology at the University of Buffalo, spoke at Grand Rounds last week. The title of his talk was "Neuropsychological Impairment in MS: Brain MRI Metrics, Cognition and Personality Change". The talk was very informative and the discussion focused on ways to correlate cognitive dysfunction with a variety of MRI parameters.
Our third floor expansion plans are well under way!! We hope to have the MRI facility up and running after the New Year. For a preview, click on the link below, which leads to renditions provided by our architectural firm, Yoshihara McKee, who were also our original architects for the Center.
http://www.yoshiharamckee.com/PROJECTS/institutional/imsmp2.html
MSRCNY RECEIVES APPROVAL FOR GROUNDBREAKING STEM CELL TRIAL IN MULTIPLE SCLEROSIS
Landmark Study Targets Repair and Regeneration for MS Patients
New York, NY- November 21, 2011- The Multiple Sclerosis Research Center of New York (MSRCNY) and the International Cellular Medicine Society (ICMS) jointly announced today the ICMS Institutional Review Board’s (IRB) approval of the first study to use autologous brain-like or neural stem cells for multiple sclerosis.
